Adverum Biotechnologies, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 11/10/2025 | 3.06 M | $13.85 M | 0.00% | 14.55% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 2.08 M | $9.41 M | 94.29% | 9.89% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 1.67 M | $7.56 M | -7.14% | 7.94% |
| VANGUARD GROUP INC | 11/07/2025 | 872.04 K | $3.95 M | -1.35% | 4.15% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 541.67 K | $2.45 M | 0.00% | 2.58% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 402.58 K | $1.82 M | -19.04% | 1.92% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 363.50 K | $1.65 M | -36.30% | 1.73% |
| PALE FIRE CAPITAL SE | 11/13/2025 | 363.28 K | $1.65 M | 1.27% | 1.73% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 324.42 K | $1.47 M | -5.23% | 1.54% |
| BLACKROCK, INC. | 11/12/2025 | 311.39 K | $1.41 M | -24.87% | 1.48% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 287.25 K | $1.30 M | 0.00% | 1.37% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 234.54 K | $1.06 M | -18.01% | 1.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 184.76 K | $837.32 K | 0.00% | 0.88% |
| REGENERON PHARMACEUTICALS, INC. | 11/07/2025 | 180.91 K | $819.52 K | 0.00% | 0.86% |
| WAVERLY ADVISORS, LLC | 11/14/2025 | 160.99 K | $729.29 K | 0.26% | 0.77% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 88.67 K | $401.68 K | 372.73% | 0.42% |
| STATE STREET CORP | 11/14/2025 | 68.73 K | $311.37 K | -0.13% | 0.33% |
| QUINN OPPORTUNITY PARTNERS LLC | 11/13/2025 | 41.42 K | $187.62 K | 0.00% | 0.20% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 38.07 K | $172.46 K | 256.44% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 31.20 K | $141.34 K | 100.00% | 0.15% |
| MARSHALL WACE, LLP | 11/13/2025 | 28.37 K | $128.50 K | -42.84% | 0.14% |
| NORTHERN TRUST CORP | 11/14/2025 | 28.06 K | $127.10 K | -18.41% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 26.26 K | $118.94 K | -55.66% | 0.13% |
| CITADEL ADVISORS LLC | 11/14/2025 | 24.10 K | $109.17 K | 100.00% | 0.11% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 21.73 K | $98.44 K | -29.17% | 0.10% |
| MORGAN STANLEY | 11/14/2025 | 17.56 K | $79.53 K | -66.84% | 0.08% |
| CITADEL ADVISORS LLC | 11/14/2025 | 17.27 K | $78.22 K | -77.94% | 0.08% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 17.15 K | $77.70 K | -35.88% | 0.08% |
| ROYAL BANK OF CANADA | 11/14/2025 | 13.47 K | $61.00 K | 386.28% | 0.06% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 10/31/2025 | 12.81 K | $58.01 K | 100.00% | 0.06% |
| XTX TOPCO LTD | 11/14/2025 | 12.66 K | $57.33 K | -57.47% | 0.06% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 11.27 K | $51.06 K | -47.94% | 0.05% |
| UBS GROUP AG | 11/13/2025 | 5.59 K | $25.30 K | -60.59% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 3.61 K | $16.37 K | -91.24% | 0.02% |
| FMR LLC | 11/13/2025 | 1.93 K | $8.76 K | -16.82% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.69 K | $7.69 K | 0.00% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 1.00 K | $4.51 K | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 540 | $2.45 K | -31.30% | 0.00% |
| PHYSICIAN WEALTH ADVISORS, INC. | 11/04/2025 | 217 | $984 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 182 | $824 | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 12/02/2025 | 102 | $463 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 84 | $381 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 11/13/2025 | 50 | $227 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 30 | $136 | -85.98% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 21 | $96 | 100.00% | 0.00% |
| GHP INVESTMENT ADVISORS, INC. | 10/31/2025 | 20 | $91 | 0.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 19 | $86 | 100.00% | 0.00% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1 | $5 | 0.00% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 10/10/2025 | 1 | $5 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Adverum Biotechnologies, Inc. institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of Adverum Biotechnologies, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 3.06 M
Frazier Life Sciences Management, L.P.: 2.08 M
TCG Crossover Management, LLC: 1.67 M
VANGUARD GROUP INC: 872,041
5AM Venture Management, LLC: 541,666
GOLDMAN SACHS GROUP INC: 402,581
54.68% of Adverum Biotechnologies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 31.54 M shares in the last 24 months. This purchase volume represents approximately $134.38 M in transactions.